SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹7.92 Cr | ₹-5.20 Cr | ₹3.17 Cr | ₹7.99 Cr | ₹0.54 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹7.92 Cr |
| Mar2024 | ₹-5.20 Cr |
| Mar2023 | ₹3.17 Cr |
| Mar2022 | ₹7.99 Cr |
| Mar2021 | ₹0.54 Cr |
How is Cash Flow from Operating Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.92 Cr | Positive | |
| Mar2024 | ₹-5.20 Cr | Negative | |
| Mar2023 | ₹3.17 Cr | -60.32 | |
| Mar2022 | ₹7.99 Cr | 1,387.71 | |
| Mar2021 | ₹0.54 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,329.8 Cr | -2.6% | 0.6% | 108.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -2.6% |
0.6% |
108.2% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses